Endometriosis is a medical condition in females related to gynecology. It is a condition of formation of endometrial cells. Seen typically during the reproductive period of a woman it affects approximately every 1 out of 10 women. The reproductive age in women being long starting from commencement of menstruation to menopause the chances of attack get higher. Endometriosis is a state in which the endometrial tissues which are essentially located in the uterus are found in other locales inside the body. These other locales include pelvic sidewall, Pouch of Douglas, fallopian tubes, uterosacral ligaments etc in particular and anywhere inside the pelvic cavity in general. Other not so common locations are intestines, bowels, appendix, colon et...
Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of HealthTronics, Inc.
CHADDS FORD, Pa., July 2 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced the successful completion of the tender offer by its wholly owned subsidiary, HT Acquisition Corp., for all of the outstanding shares of common stock of HealthTronics, Inc.
Endo to Present at Jefferies 2010 Global Life Sciences Conference
CHADDS FORD, Pa., June 8 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the Jefferies 2010 Global Life Sciences Conference on Thursday, June 10, 2010, at 2:00 p.m.
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
AUSTIN, Texas, May 5 /PRNewswire-FirstCall/ -- HealthTronics, Inc. (Nasdaq: HTRN), a leading provider of urological products and services, today announced that it has signed a definitive merger agreement with Endo Pharmaceuticals (Nasdaq: ENDP) pursuant to which Endo will acquire HealthTronics.
Endo Pharmaceuticals To Acquire HealthTronics To Expand Its Delivery of Diversified Urology Treatment and Diagnostic Solutions
CHADDS FORD, Pa., May 5 /PRNewswire-FirstCall/ --
HealthTronics is a Leading Provider of Urologic Products and ServicesAll Cash Transaction with Purchase Price of $223 Million Plus Assumed Net DebtAcquisition Accretive to 2010 Adjusted Earnings Per ShareDiversifies Endo Revenue Stream and Product Offering in UrologyContinuing to diversify, move into new growth areas beyond pharmaceuticals, and strengthen its commitment to improved patient outcomes in urology, Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement to acquire HealthTronics, Inc.
| Related News: |